Loss of heterozygosity on chromosome 6q correlates with decreased thrombospondin-2 expression in human salivary gland carcinomas
- PMID: 12824879
- PMCID: PMC11160221
- DOI: 10.1111/j.1349-7006.2003.tb01478.x
Loss of heterozygosity on chromosome 6q correlates with decreased thrombospondin-2 expression in human salivary gland carcinomas
Abstract
Since loss of heterozygosity (LOH) on the long arm of chromosome 6q is frequently observed in salivary gland carcinomas, we examined 28 salivary gland carcinomas using 24 microsat- ellite markers mapping to 6q15-27 to identify the commonly deleted region that we felt might contain one or more tumor suppressor genes. LOH was detected in at least one locus in 10 of 28 tumors (35.7%). The most frequently deleted regions occurred between D6S1581 and D6S305 (LOH cluster region 1 (LCR1) and between D6S297 and D6S1590 (LCR2). LOH was observed in 60% of adenoid cystic carcinomas (ACC) and in 57.1% of mucoepidermoid carcinomas (MEC), but was not observed in any locus in any other histological subtypes studied. The gene encoding for thrombospondin-2 (TSP-2) is located in LCR2 and 8 of 9 tumors demonstrating LOH in this region also showed significantly decreased TSP-2 expression by immunohistochemistry. As TSP-2 is a potent inhibitor of tumor growth and angiogenesis, we examined whether TSP-2 expression correlated to microvascular angiogenesis in these tumors and discovered that microvessel counts were significantly higher in lesions with decreased TSP-2 expression (P = 0.02). Our results suggest that 6q LOH may be a significant event in salivary gland carcinogenesis, particularly in ACC and MEC, and that the correlated decrease of TSP-2 expression also plays a critical role.
Similar articles
-
Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands.Oral Oncol. 2001 Apr;37(3):315-22. doi: 10.1016/s1368-8375(00)00083-x. Oral Oncol. 2001. PMID: 11287288
-
A refined localization of two deleted regions in chromosome 6q associated with salivary gland carcinomas.Oncogene. 1998 Jan 8;16(1):83-8. doi: 10.1038/sj.onc.1201480. Oncogene. 1998. PMID: 9467946
-
Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas.Hum Pathol. 1999 Oct;30(10):1242-6. doi: 10.1016/s0046-8177(99)90044-8. Hum Pathol. 1999. PMID: 10534174
-
Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.Int J Immunopathol Pharmacol. 2007 Oct-Dec;20(4):779-89. doi: 10.1177/039463200702000414. Int J Immunopathol Pharmacol. 2007. PMID: 18179751
-
[New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].Cesk Patol. 2016;52(3):139-45. Cesk Patol. 2016. PMID: 27526014 Review. Czech.
Cited by
-
Translocation t(6;14) as the sole chromosomal abnormality in adenoid cystic carcinoma of the base of tongue.Head Neck Pathol. 2007 Dec;1(2):165-8. doi: 10.1007/s12105-007-0030-5. Epub 2007 Oct 26. Head Neck Pathol. 2007. PMID: 20614269 Free PMC article.
-
Downregulation of microRNA-1246 inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting thrombospondin-2.Oncol Lett. 2019 Sep;18(3):2491-2499. doi: 10.3892/ol.2019.10571. Epub 2019 Jul 5. Oncol Lett. 2019. PMID: 31404330 Free PMC article.
-
Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type.Cell Oncol (Dordr). 2011 Aug;34(4):369-79. doi: 10.1007/s13402-011-0037-5. Epub 2011 May 4. Cell Oncol (Dordr). 2011. PMID: 21541734
-
Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer.Dose Response. 2010 Apr 23;8(3):253-84. doi: 10.2203/dose-response.09-049.Reynolds. Dose Response. 2010. PMID: 20877487 Free PMC article.
-
Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.Clin Cancer Res. 2010 Oct 1;16(19):4722-31. doi: 10.1158/1078-0432.CCR-10-0463. Epub 2010 Aug 11. Clin Cancer Res. 2010. PMID: 20702610 Free PMC article.
References
-
- Johns ME, Goldsmith MM. Incidence, diagnosis, and classification of salivary gland tumors. Part 1. Oncology (Huntingt) 1989; 3: 47–56. - PubMed
-
- Johns ME, Goldsmith MM. Current management of salivary gland tumors. Part 2. Oncology (Huntingt) 1989; 3: 85–91. - PubMed
-
- Johns MM 3rd, Westra WH, Califano JA, Eisele D, Koch WM, Sidransky D. Allelotype of salivary gland tumors. Cancer Res 1996; 56: 1151–4. - PubMed
-
- El‐Naggar AK, Hurr K, Kagan J, Gillenwater A, Callender D, Luna MA, Batsakis JG. Genotypic alterations in benign and malignant salivary gland tumors: histogenetic and clinical implications. Am J Surg Pathol 1997; 21: 691–7. - PubMed
-
- Cerilli LA, Swartzbaugh JR, Saadut R, Marshall CE, Rumpel CA, Moskaluk CA, Frierson HE Jr. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum Pathol 1999; 30: 1242–6. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous